Guidelines on the diagnosis and investigation of AL amyloidosis

British Journal of Haematology

Volumn 168, Issue 2, 2015, Pages 207-218

  Gillmore, Julian D ^a   Wechalekar, Ashutosh ^a   Bird, Jenny ^b   Cavenagh, Jamie ^c   Hawkins, Stephen ^d   Kazmi, Majid ^e   Lachmann, Helen J ^a   Hawkins, Philip N ^a   Pratt, Guy ^f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

AL; Amyloid; Amyloidosis; Guidelines; Light chain

Indexed keywords

AMYLOID; AMYLOID P COMPONENT; BRAIN NATRIURETIC PEPTIDE; BUTEDRONATE TECHNETIUM TC 99M; CONGO RED; TROPONIN T;

AGE DISTRIBUTION; AMYLOIDOSIS; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BIOPSY; BIREFRINGENCE; BONE MARROW BIOPSY; CARDIOVASCULAR MAGNETIC RESONANCE; CELL INFILTRATION; DELAYED DIAGNOSIS; DNA DETERMINATION; ECHOCARDIOGRAPHY; FUNCTION TEST; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; NERVE CONDUCTION; PATIENT CARE; PATIENT IDENTIFICATION; PLASMA CELL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SCINTIGRAPHY; SCORING SYSTEM; SEQUENCE ANALYSIS;

AMYLOIDOSIS; HUMANS;

EID: 84923845203     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13156     Document Type: Article

References (59)

1. Abraham, R.S., Geyer, S.M., Price-Troska, T.L., Allmer, C., Kyle, R.A., Gertz, M.A. & Fonseca, R. (2003) Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL). Blood, 101, 3801-3808.
2. Bochtler, T., Hegenbart, U., Cremer, F.W., Heiss, C., Benner, A., Hose, D., Moos, M., Bila, J., Bartram, C.R., Ho, A.D., Goldschmidt, H., Jauch, A. & Schonland, S.O. (2008) Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability. Blood, 111, 4700-4705.
3. Bochtler, T., Hegenbart, U., Heiss, C., Benner, A., Moos, M., Seckinger, A., Pschowski-Zuck, S., Kirn, D., Neben, K., Bartram, C.R., Ho, A.D., Goldschmidt, H., Hose, D., Jauch, A. & Schonland, S.O. (2011) Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14). Blood, 117, 3809-3815.
4. Booth, D.R., Sunde, M., Bellotti, V., Robinson, C.V., Hutchinson, W.L., Fraser, P.E., Hawkins, P.N., Dobson, C.M., Radford, S.E., Blake, C.C.F. & Pepys, M.B. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature, 385, 787-793.
5. Bradwell, A.R., Carr-Smith, H.D., Mead, G.P., Tang, L.X., Showell, P.J., Drayson, M.T. & Drew, R. (2001) Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clinical Chemistry, 47, 673-680.
6. Brambilla, F., Lavatelli, F., Di Silvestre, D., Valentini, V., Rossi, R., Palladini, G., Obici, L., Verga, L., Mauri, P. & Merlini, G. (2012) Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. Blood, 119, 1844-1847.
7. Bryce, A.H., Ketterling, R.P., Gertz, M.A., Lacy, M., Knudson, R.A., Zeldenrust, S., Kumar, S., Hayman, S., Buadi, F., Kyle, R.A., Greipp, P.R., Lust, J.A., Russell, S., Rajkumar, S.V., Fonseca, R. & Dispenzieri, A. (2009) Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis. Haematologica, 94, 380-386.
8. Choufani, E.B., Sanchorawala, V., Ernst, T., Quillen, K., Skinner, M., Wright, D.G. & Seldin, D.C. (2001) Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood, 97, 1885-1887.
9. L germ line gene use and clonal plasma cell burden. Blood, 98, 714-720.
10. Dispenzieri, A., Gertz, M.A., Kyle, R.A., Lacy, M.Q., Burritt, M.F., Therneau, T.M., Greipp, P.R., Witzig, T.E., Lust, J.A., Rajkumar, S.V., Fonseca, R., Zeldenrust, S.R., McGregor, C.G. & Jaffe, A.S. (2004) Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. Journal of Clinical Oncology, 22, 3751-3757.
11. Dispenzieri, A., Zhang, L., Katzmann, J.A., Snyder, M., Blood, E., Degoey, R., Henderson, K., Kyle, R.A., Oken, M.M., Bradwell, A.R. & Greipp, P.R. (2008) Appraisal of immunoglobulin free light chain as a marker of response. Blood, 111, 4908-4915.
12. Dubrey, S., Pollak, A., Skinner, M. & Falk, R.H. (1995) Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. British Heart Journal, 74, 541-544.
13. Duston, M.A., Skinner, M., Shirahama, T. & Cohen, A.S. (1987) The diagnosis of amyloidosis by abdominal fat aspiration. Analysis of four years' experience. American Journal of Medicine, 82, 412-414.
14. Falk, R.H., Comenzo, R.L. & Skinner, M. (1997) The systemic amyloidoses. New England Journal of Medicine, 337, 898-909.
15. Furie, B., Voo, L., McAdam, K.P. & Furie, B.C. (1981) Mechanism of factor X deficiency in systemic amyloidosis. New England Journal of Medicine, 304, 827-830.
16. Gertz, M.A. & Merlini, G. (2010) Definition of organ involvement and response to treatment in AL amyloidosis: an updated consensus opinion. Amyloid: Journal of Protein Folding Disorders, 17(Suppl. 1), 48-49.
17. Gertz, M.A., Comenzo, R., Falk, R.H., Fermand, J.P., Hazenberg, B.P., Hawkins, P.N., Merlini, G., Moreau, P., Ronco, P., Sanchorawala, V., Sezer, O., Solomon, A. & Grateau, G. (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. American Journal of Hematology, 79, 319-328.
18. Gillmore, J.D., Hawkins, P.N. & Pepys, M.B. (1997) Amyloidosis: a review of recent diagnostic and therapeutic developments. British Journal of Haematology, 99, 245-256.
19. Harrison, C.J., azzullo, H., Ross, F.M., Cheung, K.L., Gerrard, G., Harewood, L., Mehta, A., Lachmann, H.J., Hawkins, P.N. & Orchard, K.H. (2002) Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis. British Journal of Haematology, 117, 427-435.
20. Hawkins, P.N. (2002) Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Current Opinion in Nephrology and Hypertension, 11, 649-655.
21. 123I-labeled serum amyloid P component. New England Journal of Medicine, 323, 508-513.
22. Hosch, W., Bock, M., Libicher, M., Ley, S., Hegenbart, U., Dengler, T.J., Katus, H.A., Kauczor, H.U., Kauffmann, G.W. & Kristen, A.V. (2007) MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis. Investigative Radiology, 42, 636-642.
23. Hutchison, C.A., Harding, S., Hewins, P., Mead, G.P., Townsend, J., Bradwell, A.R. & Cockwell, P. (2008) Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. Clinical Journal of the American Society of Nephrology, 3, 1684-1690.
24. International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. British Journal of Haematology, 121, 749-757.
25. Kumar, S.K., Gertz, M.A., Lacy, M.Q., Dingli, D., Hayman, S.R., Buadi, F.K., Short-Detweiler, K., Zeldenrust, S.R., Leung, N., Greipp, P.R., Lust, J.A., Russell, S.J., Kyle, R.A., Rajkumar, S.V. & Dispenzieri, A. (2011) Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clinic Proceedings, 86, 12-18.
26. Kumar, S., Dispenzieri, A., Lacy, M.Q., Hayman, S.R., Buadi, F.K., Colby, C., Laumann, K., Zeldenrust, S.R., Leung, N., Dingli, D., Greipp, P.R., Lust, J.A., Russell, S.J., Kyle, R.A., Rajkumar, S.V. & Gertz, M.A. (2012) Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. Journal of Clinical Oncology, 30, 989-995.
27. Kyle, R.A. & Gertz, M.A. (1995) Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Seminars in Hematology, 32, 45-59.
28. Kyle, R.A., Greipp, P.R. & O'Fallon, W.M. (1986) Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases. Blood, 68, 220-224.
29. Kyle, R.A., Linos, A., Beard, C.M., Linke, R.P., Gertz, M.A., O'Fallon, W.M. & Kurland, L.T. (1992) Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood, 79, 1817-1822.
30. Kyle, R.A., Gertz, M.A., Greipp, P.R., Witzig, T.E., Lust, J.A., Lacy, M.Q. & Therneau, T.M. (1999) Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood, 93, 1062-1066.
31. Lachmann, H.J., Booth, D.R., Booth, S.E., Bybee, A., Gilbertson, J.A., Gillmore, J.D., Pepys, M.B. & Hawkins, P.N. (2002) Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. New England Journal of Medicine, 346, 1786-1791.
32. Lachmann, H.J., Gallimore, R., Gillmore, J.D., Carr-Smith, H.D., Bradwell, A.R., Pepys, M.B. & Hawkins, P.N. (2003) Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. British Journal of Haematology, 122, 78-84.
33. Libby, C.A., Skinner, M. & Cohen, A.S. (1983) Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Archives of Internal Medicine, 143, 1549-1552.
34. 123I serum amyloid P component scintigraphy in 484 patients. Gut, 42, 727-734.
35. Maceira, A.M., Oshi, J., Prasad, S.K., Moon, J.C., Perugini, E., Harding, I., Sheppard, M.N., Poole-Wilson, P.A., Hawkins, P.N. & Pennell, D.J. (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation, 111, 186-193.
36. Maceira, A.M., Prasad, S.K., Hawkins, P.N., Roughton, M. & Pennell, D.J. (2008) Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. Journal of Cardiovascular Magnetic Resonance, 10, 54.
37. McKenna, R.W., Kyle, R.A., Kuehl, W.M., Grogan, T.M., Harris, N.L. & Coupland, R.W. (2008) Plasma cell neoplasms. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (eds by S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman ), pp. 200-213. IARC, Lyon.
38. Merlini, G. & Palladini, G. (2008) Amyloidosis: is a cure possible? Annals of Oncology, 19(Suppl. 4), iv63-iv66.
39. Mumford, A.D., O'Donnell, J., Gillmore, J.D., Manning, R.A., Hawkins, P.N. & Laffan, M. (2000) Bleeding symptoms and coagulation abnormalities in 337 patients with AL amyloidosis. British Journal of Haematology, 110, 454-460.
40. Palladini, G., Campana, C., Klersy, C., Balduini, A., Vadacca, G., Perfetti, V., Perlini, S., Obici, L., Ascari, E., d'Eril, G.M., Moratti, R. & Merlini, G. (2003) Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation, 107, 2440-2445.
41. Palladini, G., Gertz, M.A., Kumar, S., Wechalekar, A., Hawkins, P.N., Schonland, S., Hegenbart, U., Comenzo, R., Kastritis, E., Dimopoulos, M.A., Jaccard, A., Kiersy, C. & Merlini, G. (2010a) Validation of the critieria of response to treatment in AL amylodiosis. American Society of Hematology, 116, 1364.
42. Palladini, G., Barassi, A., Klersy, C., Pacciolla, R., Milani, P., Sarais, G., Perlini, S., Albertini, R., Russo, P., Foli, A., Bragotti, L.Z., Obici, L., Moratti, R., Melzid'Eril, G.V. & Merlini, G. (2010b) The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis. Blood, 116, 3426-3430.
43. Paiva, B., Vídriales, M.B., Pérez, J.J., López- Berges, M.C., García-Sanz, R., Ocio, E.M., de Las Heras, N., Cuello, R., García de Coca, A., Pardal, E., Alonso, J., Sierra, M., Bárez, A., Hernández, J., Suárez, L., Galende, J., Mateos, M.V. & San Miguel, J.F. (2011) The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis. Blood, 117, 3613-3616.
44. Pinney, J.H., Lachmann, H.J., Bansi, L., Wechalekar, A.D., Gilbertson, J.A., Rowczenio, D., Sattianayagam, P.T., Gibbs, S.D., Orlandi, E., Wassef, N.L., Bradwell, A.R., Hawkins, P.N. & Gillmore, J.D. (2011) Outcome in renal Al amyloidosis after chemotherapy. Journal of Clinical Oncology, 29, 674-681.
45. Pinney, J.H., Smith, C.J., Taube, J.B., Lachmann, H.J., Venner, C.P., Gibbs, S.D., Dungu, J., Banypersad, S.M., Wechalekar, A.D., Whelan, C.J., Hawkins, P.N. & Gillmore, J.D. (2013) Systemic Amyloidosis in England: an epidemiological study. British Journal of Haematology, 161, 525-532.
46. Porciani, M.C., Lilli, A., Perfetto, F., Cappelli, F., Rao, C.M., Del Pace, S., Ciaccheri, M., Castelli, G., Tarquini, R., Romagnani, L., Pastorini, T., Padeletti, L. & Bergesio, F. (2009) Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis. Amyloid, 16, 63-70.
47. Rajkumar, S.V., Gertz, M.A. & Kyle, R.A. (1998a) Primary systemic amyloidosis with delayed progression to multiple myeloma. Cancer, 82, 1501-1505.
48. Rajkumar, S.V., Gertz, M.A. & Kyle, R.A. (1998b) Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. American Journal of Medicine, 104, 232-237.
49. Rapezzi, C., Quarta, C.C., Guidalotti, P.L., Longhi, S., Pettinato, C., Leone, O., Ferlini, A., Salvi, F., Gallo, P., Gagliardi, C. & Branzi, A. (2008) Usefulness of 99 mTc-DPD scintigraphy in cardiac amyloidosis. Journal of the American College of Cardiology, 51, 1509-1510; author reply 1510.
50. Rapezzi, C., Quarta, C.C., Guidalotti, P.L., Longhi, S., Pettinato, C., Leone, O., Ferlini, A., Salvi, F., Gallo, P., Gagliardi, C. & Branzi, A. (2011a) Usefulness and limitations of 99 mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. European Journal of Nuclear Medicine and Molecular Imaging, 38, 470-478.
51. Rapezzi, C., Quarta, C.C., Guidalotti, P.L., Pettinato, C., Fanti, S., Leone, O., Ferlini, A., Longhi, S., Lorenzini, M., Reggiani, L.B., Gagliardi, C., Gallo, P., Villani, C. & Salvi, F. (2011b) Role of (99 m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovascular Imaging, 4, 659-670.
52. Rodriguez, F.J., Gamez, J.D., Vrana, J.A., Theis, J.D., Giannini, C., Scheithauer, B.W., Parisi, J.E., Lucchinetti, C.F., Pendlebury, W.W., Bergen, H.R. & Dogan, A. (2008) Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissues. Laboratory Investigation, 88, 1024-1037.
53. Skinner, M., Sanchorawala, V., Seldin, D.C., Dember, L.M., Falk, R.H., Berk, J.L., Anderson, J.J., O'Hara, C., Finn, K.T., Libbey, C.A., Wiesman, J., Quillen, K., Swan, N. & Wright, D.G. (2004) High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Annals of Internal Medicine, 140, 85-93.
54. Sparrow, P., Amirabadi, A., Sussman, M.S., Paul, N. & Merchant, N. (2009) Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis. Journal of Magnetic Resonance Imaging, 30, 942-946.
55. Tennent, G.A., Cafferty, K.D., Pepys, M.B. & Hawkins, P.N. (1999) Congo red overlay immunohistochemistry aids classification of amyloid deposits. In: Amyloid and Amyloidosis 1998 (eds by R.A. Kyle & M.A. Gertz ), pp. 160-162. Parthenon Publishing, Pearl River, NY.
56. Vrana, J.A., Gamez, J.D., Madden, B.J., Theis, J.D., Bergen, H.R. & Dogan, A. (2009) Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood, 114, 4957-4959.
57. Warsame, R., Kumar, S.K., Gertz, M.A., Lacy, M.Q., Buadi, F.K., Hayman, S.R., Leung, N., Dingli, D., Lust, J.A., Lin, Y., Kapoor, P., Go, R.S., Zeldenrust, S.R., Kyle, R.A., Rajkumar, S.V. & Dispenzieri, A. (2014) Amyloidosis and interphase fluorescence in situ testing coupled and cytoplasmic staining. Amyloid Journal Conference Proceedings PA-48:146
58. Wechalekar, A.D., Hawkins, P.N. & Gillmore, J.D. (2008) Perspectives in treatment of AL amyloidosis. British Journal of Haematology, 140, 365-377.
59. Wechalekar, A.D., Gillmore, J.D., Bird, J., Cavenagh, J., Hawkins, S., Kazmi, M., Lachmann, H.J., Hawkins, P.N. & Pratt, G. (2014) Guidelines on the management of AL amyloidosis. British Journal of Haematology, doi: 10.1111/bjh.13155.